Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
MIPSOL Limited is a medical information and pharmacovigilance consultancy registered in England and Wales, founded by Dr. Sarah Hall in 2018. According to the website, its clients mainly include human and veterinary pharmaceutical companies, biotechnology companies, and related service providers. It is worth noting that MIPSOL is not a SaaS or enterprise software product in the usual sense, but rather an expert consulting and compliance support service.
Its services cover three main areas: pharmacovigilance, quality, and medical information. Pharmacovigilance services include PV system setup, UK National Contact Person support, PSMF, aggregate reports such as PSUR/PBRER/PADER/DSUR, support for safety database implementation/migration/upgrades, SDEA, process assessments, and inspection readiness. Quality services include GVP/GCP safety audits, gap analyses, and the creation of SOPs and work instructions. Medical information services include service setup, process maintenance, development of standard responses, inspection preparation, and training.
The website does not disclose pricing, packages, or standard delivery timelines, but it clearly states that work can be carried out as one-off projects, long-term collaborations, or on an ad hoc basis. As such, it is closer to a project-based consulting service, and requirements and quotations need to be discussed further via the contact form or by phone.
Its strengths lie in the founder’s more than 25 years of experience in medical information and pharmacovigilance, as well as involvement in various types of regulatory inspections and audits across GVP, GMP, GDP, GCP, and other scenarios. This can be valuable for small and mid-sized pharmaceutical companies or teams lacking in-house PV expertise. The limitations are also fairly clear: the website provides no information about a software platform, APIs, integrations, permissions, automated workflows, or other SaaS-related features. It also lacks customer case studies, pricing transparency, and detailed information on security certifications.
It is better suited to pharmaceutical companies that need to establish or optimize a pharmacovigilance system, prepare for regulatory inspections, maintain a PSMF, or conduct PV/medical information audits or training. It is not suitable for teams looking for a standardized cloud-based PV system, configurable workflows, or an enterprise-grade safety database platform.
The extracted text does not make it possible to determine its accessibility in mainland China, so this is marked as unknown.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on mipsol.co.uk official site.
mipsol.co.uk is an United Kingdom SaaS provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach mipsol.co.uk directly.